© 1997 American Heart Association, Inc.
Articles |
Bone Marrow Transplantation in Apolipoprotein E–Deficient Mice
Effect of ApoE Gene Dosage on Serum Lipid Concentrations, (ß)VLDL Catabolism, and Atherosclerosis
From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Sylvius Laboratories, Leiden University, Leiden, The Netherlands (M. Van E., N.H., Th.J.C. Van B.); SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK (J.Y., N.J.P., P.H.E.G.); and University Hospital Leiden, Department of Pediatrics, Leiden, The Netherlands (P.M.H.).
Correspondence to M. Van Eck (MSc), Division of Biopharmaceutics, Sylvius Laboratories, Leiden University, Wassenaarseweg 72, 2333 AL Leiden, PO Box 9503, 2300 RA Leiden, The Netherlands. E-mail M.Eck{at}LACDR.LeidenUniv.nl
Abstract Apolipoprotein E (apoE), a high-affinity ligand for lipoprotein receptors, is synthesized by the liver and extrahepatic tissues, including cells of the monocyte/macrophage lineage. Inactivation of the apoE gene in mice leads to a prominent increase in serum cholesterol and triglyceride levels and the development of premature atherosclerosis. In this study, the role of monocyte/macrophage-derived apoE in lipoprotein remnant metabolism and atherogenesis was assessed. The influence of apoE gene dosage on serum lipid concentrations was determined by transplantation of homozygous apoE-deficient (apoE-/-), heterozygous apoE-deficient (apoE+/-), and wild-type (apoE+/+) bone marrow in homozygous apoE-deficient mice. The concentration of apoE detected in serum was found to be gene dosage dependent, being 3.52±0.30%, 1.87±0.17%, and 0% of normal in transplanted mice receiving either apoE+/+, apoE+/-, or apoE-/- bone marrow, respectively. These low concentrations of apoE nevertheless dramatically reduced serum cholesterol levels owing to a reduction of VLDL and, to a lesser extent, LDL, while HDL levels were slightly raised. After 4 months on a "Western-type" diet, atherosclerosis was evidently reduced in mice transplanted with apoE+/+ bone marrow, compared with control transplanted mice. To study the mechanism of the lipoprotein changes on bone marrow transplantation, the in vivo turnover of autologous serum (ß)VLDL was studied. The serum half-life of (ß)VLDL in transplanted mice, compared with control apoE-deficient mice, was shortened mainly as a consequence of an increased recognition and uptake by the liver. Analysis of the relative contribution of the liver parenchymal cells, endothelial cells, and Kupffer cells (liver tissue macrophages) indicated an increased uptake by parenchymal cells, while the relative contribution of Kupffer cells was decreased. In conclusion, macrophage-derived apoE can dose-dependently reduce hypercholesterolemia in apoE-deficient mice owing to increased recognition and uptake of (ß)VLDL by parenchymal liver cells, leading to a decreased susceptibility to atherosclerosis.
Key Words: apoE deficiency • atherosclerosis • gene transfer • macrophages • VLDL
This article has been cited by other articles:
 |
|
 |
|
  J. Guo, I. Bot, R. de Nooijer, S. J. Hoffman, G. B. Stroup, E. A.L. Biessen, G. M. Benson, P. H.E. Groot, M. Van Eck, and T. J.C. Van Berkel Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice Cardiovasc Res, February 1, 2009; 81(2): 278 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Atkinson, K. R. Coenen, M. R. Plummer, M. L. Gruen, and A. H. Hasty Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E284 - E290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Van Eck, M. Hoekstra, R. Out, I. S. T. Bos, J. K. Kruijt, R. B. Hildebrand, and T. J. C. Van Berkel Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo J. Lipid Res., January 1, 2008; 49(1): 136 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Yan, M. Jauhiainen, R. B. Hildebrand, K. Willems van Dijk, T. J.C. Van Berkel, C. Ehnholm, M. Van Eck, and V. M. Olkkonen Expression of Human OSBP-Related Protein 1L in Macrophages Enhances Atherosclerotic Lesion Development in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1618 - 1624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Baldan, L. Pei, R. Lee, P. Tarr, R. K. Tangirala, M. M. Weinstein, J. Frank, A. C. Li, P. Tontonoz, and P. A. Edwards Impaired Development of Atherosclerosis in Hyperlipidemic Ldlr-/- and ApoE-/- Mice Transplanted With Abcg1-/- Bone Marrow Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2301 - 2307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Singaraja, M. Van Eck, N. Bissada, F. Zimetti, H. L. Collins, R. B. Hildebrand, A. Hayden, L. R. Brunham, M. H. Kang, J.-C. Fruchart, et al. Both Hepatic and Extrahepatic ABCA1 Have Discrete and Essential Functions in the Maintenance of Plasma High-Density Lipoprotein Cholesterol Levels In Vivo Circulation, September 19, 2006; 114(12): 1301 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bengtsson, F. To, K. Hakansson, A. Grubb, L. Branen, J. Nilsson, and S. Jovinge Lack of the Cysteine Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2151 - 2156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Combes, N. Coltel, M. Alibert, M. van Eck, C. Raymond, I. Juhan-Vague, G. E. Grau, and G. Chimini ABCA1 Gene Deletion Protects against Cerebral Malaria: Potential Pathogenic Role of Microparticles in Neuropathology Am. J. Pathol., January 1, 2005; 166(1): 295 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Branen, L. Hovgaard, M. Nitulescu, E. Bengtsson, J. Nilsson, and S. Jovinge Inhibition of Tumor Necrosis Factor-{alpha} Reduces Atherosclerosis in Apolipoprotein E Knockout Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2137 - 2142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nobuhiko, E. Suganuma, V. R. Babaev, A. Fogo, L. L. Swift, M. F. Linton, S. Fazio, I. Ichikawa, and V. Kon Angiotensin II Amplifies Macrophage-Driven Atherosclerosis Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2143 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Guo, M. Van Eck, J. Twisk, N. Maeda, G. M. Benson, P. H.E. Groot, and T. J.C. Van Berkel Transplantation of Monocyte CC-Chemokine Receptor 2-Deficient Bone Marrow Into ApoE3-Leiden Mice Inhibits Atherogenesis Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 447 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fazio, V. R. Babaev, M. E. Burleigh, A. S. Major, A. H. Hasty, and M. F. Linton Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice J. Lipid Res., October 1, 2002; 43(10): 1602 - 1609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Van Eck, I. S. T. Bos, W. E. Kaminski, E. Orso, G. Rothe, J. Twisk, A. Bottcher, E. S. Van Amersfoort, T. A. Christiansen-Weber, W.-P. Fung-Leung, et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues PNAS, April 30, 2002; 99(9): 6298 - 6303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Furbee Jr., J. K. Sawyer, and J. S. Parks Lecithin:Cholesterol Acyltransferase Deficiency Increases Atherosclerosis in the Low Density Lipoprotein Receptor and Apolipoprotein E Knockout Mice J. Biol. Chem., January 25, 2002; 277(5): 3511 - 3519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ishimori, K. Iwabuchi, S. Fujii, K. Watano, C. Iwabuchi, M. Ato, H. Chiba, S. Tanaka, A. Kitabatake, and K. Onoé Mixed allogeneic chimerism with wild-type strains ameliorates atherosclerosis in apolipoprotein E-deficient mice J. Leukoc. Biol., May 1, 2001; 69(5): 732 - 740. [Abstract] [Full Text]
|
|
|
|
|
|
M. Van Eck, M. P. J. De Winther, N. Herijgers, L. M. Havekes, M. H. Hofker, P. H. E. Groot, and T. J. C. Van Berkel Effect of Human Scavenger Receptor Class A Overexpression in Bone Marrow-Derived Cells on Cholesterol Levels and Atherosclerosis in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2600 - 2606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Shi, X. Wang, N. J. Wang, W. H. McBride, and A. J. Lusis Effect of Macrophage-Derived Apolipoprotein E on Established Atherosclerosis in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2261 - 2266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Herijgers, M. P. J. de Winther, M. Van Eck, L. M. Havekes, M. H. Hofker, P. M. Hoogerbrugge, and T. J. C. Van Berkel Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice J. Lipid Res., September 1, 2000; 41(9): 1402 - 1409. [Abstract] [Full Text]
|
|
|
|
|
|
M. Van Eck, R. Zimmermann, P. H. E. Groot, R. Zechner, and T. J. C. Van Berkel Role of Macrophage-Derived Lipoprotein Lipase in Lipoprotein Metabolism and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20 (9): e53 - e62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Thorngate, L. L. Rudel, R. L. Walzem, and D. L. Williams Low Levels of Extrahepatic Nonmacrophage ApoE Inhibit Atherosclerosis Without Correcting Hypercholesterolemia in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1939 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Herijgers, M. Van Eck, S. J. A. Korporaal, P. M. Hoogerbrugge, and T. J. C. Van Berkel Relative importance of the LDL receptor and scavenger receptor class B in the {beta}-VLDL-induced uptake and accumulation of cholesteryl esters by peritoneal macrophages J. Lipid Res., July 1, 2000; 41(7): 1163 - 1171. [Abstract] [Full Text]
|
|
|
|
|
|
M. Van Eck, N. Herijgers, K. W. Van Dijk, L. M. Havekes, M. H. Hofker, P. H. E. Groot, and T. J. C. Van Berkel Effect of Macrophage-Derived Mouse ApoE, Human ApoE3-Leiden, and Human ApoE2 (Arg158->Cys) on Cholesterol Levels and Atherosclerosis in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 119 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Hasty, M. F. Linton, L. L. Swift, and S. Fazio Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance J. Lipid Res., August 1, 1999; 40(8): 1529 - 1538. [Abstract] [Full Text]
|
|
|
|
|
|
S. Fazio, M. F. Linton, A. H. Hasty, and L. L. Swift Recycling of Apolipoprotein E in Mouse Liver J. Biol. Chem., March 19, 1999; 274(12): 8247 - 8253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schmitt and T. Grand-Perret Regulated turnover of a cell surface-associated pool of newly synthesized apolipoprotein E in HepG2 cells J. Lipid Res., January 1, 1999; 40(1): 39 - 49. [Abstract] [Full Text]
|
|
|
|
|
|
P. Carmeliet, L. Moons, and D. Collen Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis Cardiovasc Res, July 1, 1998; 39(1): 8 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Van Oosten, P. C. N. Rensen, E. S. Van Amersfoort, M. Van Eck, A.-M. Van Dam, J. J. P. Breve, T. Vogel, A. Panet, T. J. C. Van Berkel, and J. Kuiper Apolipoprotein E Protects Against Bacterial Lipopolysaccharide-induced Lethality. A NEW THERAPEUTIC APPROACH TO TREAT GRAM-NEGATIVE SEPSIS J. Biol. Chem., March 16, 2001; 276(12): 8820 - 8824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Van Eck, I. S. T. Bos, W. E. Kaminski, E. Orso, G. Rothe, J. Twisk, A. Bottcher, E. S. Van Amersfoort, T. A. Christiansen-Weber, W.-P. Fung-Leung, et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues PNAS, April 30, 2002; 99(9): 6298 - 6303. [Abstract] [Full Text] [PDF]
|
|